Login

Presentation: Packaging Progress - Ditching Plastic to Reduce Emissions | Thomas Körmendi - CEO of Elopak Group. 00:10:00

Share On Facebook Share On Twitter

Thomas Körmendi is the CEO and President of the Elopak Group.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Empowering Financial Services: Transforming Legacy Infrastructure for Client-Centricity | Stephen Bird, CEO , Abrdn .
00:10:00
Targeted Therapeutics: Patrick Lu on Sirnaomics' Innovations in RNA Interference for Critical Diseases | Patrick Y. Lu , CEO, Sirnaomics Ltd.
00:10:00
Morien Resources Corp. Presents at Metals Investor Forum 2023 | DAWSON BRISCO - President, CEO and Director of Morien Resources Corp.
00:00:00
CEL-SCI CEO Geert Kersten Exclusive May 2023 Interview - Geert Kersten , CEO, CEL-SCI Corp
00:10:00
Speaking about the mining of Bitcoin and Ethereum, Bitfarms' recent mining performance, and their aspirations to expand in Argentina | Geoff Morphy, CEO, Bitfarms LtdBITF:TOR
00:10:00
Creating the UK's First Independent Rare Earth Supply Chain
00:10:00
Exploring the Essence of Personal Growth and Technology
00:10:00
Rosario Pingaro, President and CEO of Convergenze SpA, Reflects on the Company's Journey | Rosario Pingaro, CEO, Convergenze SpA Società Benefit.
00:10:00
Understanding Disability Insurance: A Key Risk Management Strategy | Mike Murkins, Financial Planner of Syverson Strege
00:10:00
Biotech Innovator Advocates for Collaborative Healthcare Approach | André Choulika, CEO,Cellectis SA.
00:10:00
Novel Cell Therapy Approaches for Oncology Highlight Manufacturing and Commercialization Strategies at Cell | Filippo Petti, CEO, Celyad Oncology SA.
00:10:00
Boralex CEO Patrick Decostre engages in a discussion beyond pledges.

© 2017 - Neuhu+